{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:30:23Z","timestamp":1790037023232,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2045-3701-4-38","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T09:03:15Z","timestamp":1406710995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver"],"prefix":"10.1186","volume":"4","author":[{"given":"Xuan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,30]]},"reference":[{"key":"167_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrd2830","volume":"8","author":"JD Baxter","year":"2009","unstructured":"Baxter JD, Webb P: Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov. 2009, 8: 308-320. 10.1038\/nrd2830","journal-title":"Nat Rev Drug Discov"},{"key":"167_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1172\/JCI19479","volume":"112","author":"MA Lazar","year":"2003","unstructured":"Lazar MA: Thyroid hormone action: a binding contract. J Clin Invest. 2003, 112: 497-499. 10.1172\/JCI19479","journal-title":"J Clin Invest"},{"key":"167_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.7326\/0003-4819-129-2-199807150-00020","volume":"129","author":"M Helfand","year":"1998","unstructured":"Helfand M, Redfern CC: Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians. Ann Intern Med. 1998, 129: 144-158. 10.7326\/0003-4819-129-2-199807150-00020","journal-title":"Ann Intern Med"},{"key":"167_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jama.291.2.228","volume":"291","author":"MI Surks","year":"2004","unstructured":"Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ, Gorman C, Cooper RS, Weissman NJ: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004, 291: 228-238. 10.1001\/jama.291.2.228","journal-title":"JAMA"},{"key":"167_CR5","first-page":"348","volume":"14","author":"S Refetoff","year":"1993","unstructured":"Refetoff S, Weiss RE, Usala SJ: The syndromes of resistance to thyroid hormone. Endocr Rev. 1993, 14: 348-399.","journal-title":"Endocr Rev"},{"key":"167_CR6","doi-asserted-by":"publisher","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"JK Reddy","year":"2006","unstructured":"Reddy JK, Rao MS: Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol. 2006, 290: G852-G858.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Suppl 1","key":"167_CR7","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/sj.ejcn.1600744","volume":"53","author":"MK Hellerstein","year":"1999","unstructured":"Hellerstein MK: De novo lipogenesis in humans: metabolic and regulatory aspects. Eur J Clin Nutr. 1999, 53 (Suppl 1): S53-S65.","journal-title":"Eur J Clin Nutr"},{"key":"167_CR8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ: The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012, 55: 2005-2023. 10.1002\/hep.25762","journal-title":"Hepatology"},{"key":"167_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","volume":"29","author":"F Diraison","year":"2003","unstructured":"Diraison F, Moulin P, Beylot M: Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 2003, 29: 478-485. 10.1016\/S1262-3636(07)70061-7","journal-title":"Diabetes Metab"},{"key":"167_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.bpg.2013.06.014","volume":"27","author":"P Burra","year":"2013","unstructured":"Burra P: Liver abnormalities and endocrine diseases. Best Pract Res Clin Gastroenterol. 2013, 27: 553-563. 10.1016\/j.bpg.2013.06.014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"167_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00004836-200310000-00014","volume":"37","author":"S Liangpunsakul","year":"2003","unstructured":"Liangpunsakul S, Chalasani N: Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?. J Clin Gastroenterol. 2003, 37: 340-343. 10.1097\/00004836-200310000-00014","journal-title":"J Clin Gastroenterol"},{"key":"167_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","volume":"57","author":"GE Chung","year":"2012","unstructured":"Chung GE, Kim D, Kim W, Yim JY, Park MJ, Kim YJ, Yoon JH, Lee HS: Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol. 2012, 57: 150-156. 10.1016\/j.jhep.2012.02.027","journal-title":"J Hepatol"},{"key":"167_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1210\/me.2008-0311","volume":"23","author":"O Araki","year":"2009","unstructured":"Araki O, Ying H, Zhu XG, Willingham MC, Cheng SY: Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Mol Endocrinol. 2009, 23: 308-315. 10.1210\/me.2008-0311","journal-title":"Mol Endocrinol"},{"key":"167_CR14","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1210\/en.2006-0836","volume":"148","author":"YY Liu","year":"2007","unstructured":"Liu YY, Heymann RS, Moatamed F, Schultz JJ, Sobel D, Brent GA: A mutant thyroid hormone receptor alpha antagonizes peroxisome proliferator-activated receptor alpha signaling in vivo and impairs fatty acid oxidation. Endocrinology. 2007, 148: 1206-1217. 10.1210\/en.2006-0836","journal-title":"Endocrinology"},{"key":"167_CR15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","volume":"81","author":"PM Yen","year":"2001","unstructured":"Yen PM: Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001, 81: 1097-1142.","journal-title":"Physiol Rev"},{"key":"167_CR16","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1096\/fj.08-108464","volume":"22","author":"A Perra","year":"2008","unstructured":"Perra A, Simbula G, Simbula M, Pibiri M, Kowalik MA, Sulas P, Cocco MT, Ledda-Columbano GM, Columbano A: Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit\/reverse nonalcoholic fatty liver in rats. FASEB J. 2008, 22: 2981-2989. 10.1096\/fj.08-108464","journal-title":"FASEB J"},{"key":"167_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/hep.22572","volume":"49","author":"EE Cable","year":"2009","unstructured":"Cable EE, Finn PD, Stebbins JW, Hou J, Ito BR, van Poelje PD, Linemeyer DL, Erion MD: Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology. 2009, 49: 407-417. 10.1002\/hep.22572","journal-title":"Hepatology"},{"key":"167_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jhep.2011.07.014","volume":"56","author":"Y Song","year":"2012","unstructured":"Song Y, Shan S, Zhang Y, Liu W, Ding W, Ren W, Xia H, Li X, Zhang Q, Zhao L, Li X, Yan J, Ying H: Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice. J Hepatol. 2012, 56: 248-254.","journal-title":"J Hepatol"},{"key":"167_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","volume":"48","author":"G Musso","year":"2009","unstructured":"Musso G, Gambino R, Cassader M: Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009, 48: 1-26. 10.1016\/j.plipres.2008.08.001","journal-title":"Prog Lipid Res"},{"key":"167_CR20","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/en.2004-1392","volume":"146","author":"AM Zavacki","year":"2005","unstructured":"Zavacki AM, Ying H, Christoffolete MA, Aerts G, So E, Harney JW, Cheng SY, Larsen PR, Bianco AC: Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology. 2005, 146: 1568-1575. 10.1210\/en.2004-1392","journal-title":"Endocrinology"},{"key":"167_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3945\/ajcn.111.012054","volume":"94","author":"JH Wu","year":"2011","unstructured":"Wu JH, Lemaitre RN, Imamura F, King IB, Song X, Spiegelman D, Siscovick DS, Mozaffarian D: Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study. Am J Clin Nutr. 2011, 94: 431-438. 10.3945\/ajcn.111.012054","journal-title":"Am J Clin Nutr"},{"key":"167_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4162\/nrp.2013.7.4.294","volume":"7","author":"MY Park","year":"2013","unstructured":"Park MY, Mun ST: Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice. Nutr Res Pract. 2013, 7: 294-301. 10.4162\/nrp.2013.7.4.294","journal-title":"Nutr Res Pract"},{"key":"167_CR23","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1074\/jbc.M807616200","volume":"284","author":"ZZ Li","year":"2009","unstructured":"Li ZZ, Berk M, McIntyre TM, Feldstein AE: Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease ROLE OF STEAROYL-CoA DESATURASE. J Biol Chem. 2009, 284: 5637-5644. 10.1074\/jbc.M807616200","journal-title":"J Biol Chem"},{"key":"167_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0163-7827(03)00039-0","volume":"43","author":"JM Ntambi","year":"2004","unstructured":"Ntambi JM, Miyazaki M: Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res. 2004, 43: 91-104. 10.1016\/S0163-7827(03)00039-0","journal-title":"Prog Lipid Res"},{"key":"167_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/mend.14.7.0470","volume":"14","author":"X Feng","year":"2000","unstructured":"Feng X, Jiang Y, Meltzer P, Yen PM: Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol. 2000, 14: 947-955. 10.1210\/mend.14.7.0470","journal-title":"Mol Endocrinol"},{"key":"167_CR26","first-page":"1257","volume":"16","author":"A Flores-Morales","year":"2002","unstructured":"Flores-Morales A, Gullberg H, Fernandez L, Stahlberg N, Lee NH, Vennstrom B, Norstedt G: Patterns of liver gene expression governed by TR beta. Mol Endocrinol. 2002, 16: 1257-1268.","journal-title":"Mol Endocrinol"},{"key":"167_CR27","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1172\/JCI60580","volume":"122","author":"RA Sinha","year":"2012","unstructured":"Sinha RA, You SH, Zhou J, Siddique MM, Bay BH, Zhu XG, Privalsky ML, Cheng SY, Stevens RD, Summers SA, Newgard CB, Lazar MA, Yen PM, Newgard CB, Lazar MA, Yen PM: Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest. 2012, 122: 2428-2438. 10.1172\/JCI60580","journal-title":"J Clin Invest"},{"key":"167_CR28","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1074\/jbc.M211062200","volume":"278","author":"L Jackson-Hayes","year":"2003","unstructured":"Jackson-Hayes L, Song S, Lavrentyev EN, Jansen MS, Hillgartner FB, Tian L, Wood PA, Cook GA, Park EA: A thyroid hormone response unit formed between the promoter and first intron of the carnitine palmitoyltransferase-Ialpha gene mediates the liver-specific induction by thyroid hormone. J Biol Chem. 2003, 278: 7964-7972. 10.1074\/jbc.M211062200","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"167_CR29","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/S0378-3782(01)00201-8","volume":"65","author":"E Larque","year":"2001","unstructured":"Larque E, Zamora S, Gil A: Dietary trans fatty acids in early life: a review. Early Hum Dev. 2001, 65 (Suppl): S31-S41.","journal-title":"Early Hum Dev"},{"key":"167_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/en.2012-1559","volume":"154","author":"K Hashimoto","year":"2013","unstructured":"Hashimoto K, Ishida E, Miura A, Ozawa A, Shibusawa N, Satoh T, Okada S, Yamada M, Mori M: Human stearoyl-CoA desaturase 1 (SCD-1) gene expression is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptor to the gene promoter. Endocrinology. 2013, 154: 537-549. 10.1210\/en.2012-1559","journal-title":"Endocrinology"},{"key":"167_CR31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1006\/bbrc.1997.6550","volume":"233","author":"KM Waters","year":"1997","unstructured":"Waters KM, Miller CW, Ntambi JM: Localization of a negative thyroid hormone-response region in hepatic stearoyl-CoA desaturase gene 1. Biochem Biophys Res Commun. 1997, 233: 838-843. 10.1006\/bbrc.1997.6550","journal-title":"Biochem Biophys Res Commun"},{"key":"167_CR32","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1073\/pnas.0401627101","volume":"101","author":"P Dobrzyn","year":"2004","unstructured":"Dobrzyn P, Dobrzyn A, Miyazaki M, Cohen P, Asilmaz E, Hardie DG, Friedman JM, Ntambi JM: Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A. 2004, 101: 6409-6414. 10.1073\/pnas.0401627101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"167_CR33","doi-asserted-by":"publisher","first-page":"15490","DOI":"10.1073\/pnas.0702759104","volume":"104","author":"MD Erion","year":"2007","unstructured":"Erion MD, Cable EE, Ito BR, Jiang H, Fujitaki JM, Finn PD, Zhang BH, Hou J, Boyer SH, van Poelje PD, Linemeyer DL: Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci U S A. 2007, 104: 15490-15495. 10.1073\/pnas.0702759104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"167_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos MJ, Sanyal AJ: A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007, 46: 1081-1090. 10.1002\/hep.21763","journal-title":"Hepatology"},{"key":"167_CR35","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1210\/en.2008-1085","volume":"150","author":"M Vujovic","year":"2009","unstructured":"Vujovic M, Nordstrom K, Gauthier K, Flamant F, Visser TJ, Vennstrom B, Mittag J: Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism. Endocrinology. 2009, 150: 2940-2947. 10.1210\/en.2008-1085","journal-title":"Endocrinology"},{"key":"167_CR36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1113\/expphysiol.2009.048751","volume":"94","author":"AJ Forhead","year":"2009","unstructured":"Forhead AJ, Cutts S, Matthews PA, Fowden AL: Role of thyroid hormones in the developmental control of tissue glycogen in fetal sheep near term. Exp Physiol. 2009, 94: 1079-1087. 10.1113\/expphysiol.2009.048751","journal-title":"Exp Physiol"},{"key":"167_CR37","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1210\/en.2010-0631","volume":"151","author":"A Marsili","year":"2010","unstructured":"Marsili A, Ramadan W, Harney JW, Mulcahey M, Castroneves LA, Goemann IM, Wajner SM, Huang SA, Zavacki AM, Maia AL, Dentice M, Salvatore D, Silva JE, Larsen PR: Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism. Endocrinology. 2010, 151: 5952-5960. 10.1210\/en.2010-0631","journal-title":"Endocrinology"},{"key":"167_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3945\/ajcn.113.061218","volume":"98","author":"G Zong","year":"2013","unstructured":"Zong G, Zhu J, Sun L, Ye X, Lu L, Jin Q, Zheng H, Yu Z, Zhu Z, Li H, Sun Q, Lin X: Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese. Am J Clin Nutr. 2013, 98: 319-326. 10.3945\/ajcn.113.061218","journal-title":"Am J Clin Nutr"},{"key":"167_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.freeradbiomed.2014.02.024","volume":"70C","author":"Y Huang","year":"2014","unstructured":"Huang Y, Zhu M, Li Z, Sa R, Chu Q, Zhang Q, Zhang H, Tang W, Zhang M, Yin H: Mass spectrometry-based metabolomic profiling identifies alterations in salivary redox status and fatty acid metabolism in response to inflammation and oxidative stress in periodontal disease. Free Radic Biol Med. 2014, 70C: 223-232.","journal-title":"Free Radic Biol Med"},{"key":"167_CR40","doi-asserted-by":"publisher","first-page":"e41478","DOI":"10.1371\/journal.pone.0041478","volume":"7","author":"D Zhang","year":"2012","unstructured":"Zhang D, Li X, Chen C, Li Y, Zhao L, Jing Y, Liu W, Wang X, Zhang Y, Xia H, Chang Y, Gao X, Yan J, Ying H: Attenuation of p38-mediated miR-1\/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration. PLoS One. 2012, 7: e41478. 10.1371\/journal.pone.0041478","journal-title":"PLoS One"}],"container-title":["Cell & Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2045-3701-4-38.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:14:54Z","timestamp":1630559694000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/2045-3701-4-38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1186\/2045-3701-4-38","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,30]]},"assertion":[{"value":"12 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}